Reduced expression of miR-564 is associated with worse prognosis in patients with osteosarcoma.

CONCLUSIONS: Overall, our data for the first time suggest that downregulated miR-564 may be used as a novel prognosis predictor of OS. PMID: 30280765 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research